Fighting a Smarter War Against Cancer: Linking Policy to the Patient, Symposium 2011

 

Day 1: Thursday Session  |  Day 2: Friday Session


Day 2: Friday, December 2, 2011

Defining Value in Cancer Care

 

Cancer Care 2011: The Cost of Care in the U.S. and its Impact

 

M. Gregg Bloche, MD, JD
Professor of Law
Georgetown University Law Center
Co-Director
Georgetown-Johns Hopkins Joint Program in Law and Public Health


Bending the Cost Curve in Cancer

 

Thomas Smith, MD, FACP
Director of Palliative Medicine
Johns Hopkins Medical Institutions
Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center


The Gatekeepers: Safety and Efficacy vs. Value

 

Gregory H. Reaman, MD
Associate Director
Office of Oncology Drug Products
Office of New Drugs
Center for Drug Evaluation and Research
U.S. Food and Drug Administration


The Impact of Guideline Based Medicine: The NCCN Process and Perspective

 

Jordan Berlin, MD
Professor of Medicine
Vanderbilt University School of Medicine
Clinical Director, GI Oncology Program & Medical Director, Clinical Trials Shared Resources
Vanderbilt-Ingram Cancer Center


The Gatekeepers: Roundtable Discussion

 

Moderator:
M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center
Co-Director, Georgetown-Johns Hopkins Joint Program in Law and Public Health

Panelists:
Ira M. Klein, MD, MBA, FACP
Chief of Staff
Office of the Chief Medical Officer
Aetna, Inc.

J. Russell Hoverman, MD, PhD
Vice President of Managed Care, Texas Oncology
Medical Director of Managed Care and Disease Management
The US Oncology Network

Louis B. Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality
Centers for Medicare & Medicaid Services
U.S. Department of Health & Human Services


Measuring Value in Cancer: U.S. & Global Perspectives Roundtable Discussion

 

Moderator:
Arnold L. Potosky, PhD
Director of Health Services Research
Georgetown Lombardi Comprehensive Cancer Center

Panelists:
Paul Wallace, MD
Senior Vice President and Director
Center for Comparative Effectiveness Research
The Lewin Group

Mona Sabharwal, PharmD
Executive Director
Pan-Canadian Oncology Drug Review

Arthur "Art" Small, MD
Head, Oncology Outcomes Research
U.S. Medical Affairs, Biometrics, Health Outcomes & Payer Support, Genentech, Inc.

Margaret "Mimi" Mahon, PhD, RN, FAAN
Palliative Care Nurse Practitioner
Associate Professor, School of Nursing, George Mason University, College of Health & Human Services


The Stakeholders' Perspectives: What Do We Want in the Clinic? Roundtable Discussion

 

Moderator:
Ellen V. Sigal, PhD
Chairperson and Founder
Friends of Cancer Research

Panelists and Ruesch Center Advocacy Board Members:
Carolyn R. "Bo" Aldige
President and Founder
Prevent Cancer Foundation

Carlea Bauman
President
Fight Colorectal Cancer

Julie M. Fleshman, JD, MBA
President and Chief Executive Officer
Pancreatic Cancer Action Network

Gilad S. Gordon, MD, MBA
President
ORRA Group, LLC

Jasmine Greenamyer
Chief Operating Officer
Colon Cancer Alliance

Mace L. Rothenberg, MD
Senior Vice President
Clinical Development & Medical Affairs
Oncology Business Unit, Pfizer, Inc.

Michael Sapienza
Executive Director and Founder
Chris4Life Colon Cancer Foundation

Kim Thiboldeaux
President and Chief Executive Officer
Cancer Support Community


View videos from Day 1 of the Symposium.